09.01.05
NutraCea, El Dorado Hills, CA, has released the results of the second phase open label clinical trial conducted at the University of New Mexico (UNM) School of Medicine by stroke specialist, Dr. Glenn Graham, Director, Cerebrovascular Disorders Program and Principal Investigator and Dr. Wade Harris, Resident and Co-Investigator on the “Effects of Stabilized Rice Bran RiSolubles on Inhibition of Platelet Aggregation and Lipid Profile.” Of the 39 patients who completed the study, there was an average of a 12% reduction in total cholesterol and a 10% reduction of LDL cholesterol, which are considered to be statistically significant findings. The triglycerides were also reduced by 10% and HDL levels remained about the same.